A new kind of health venture fund.
Springboard Health Ventures is the institutional expression of the SHA thesis — bringing together our syndicate's deal flow, expert network, and exceptional track record under a new institutional-grade fund structure. Launching soon.
We are witnessing a structural shift in health tech and life sciences innovation. Computing power, advanced diagnostics, and automation are converging to reshape how healthcare is delivered and discovered.
Yet, there remains a persistent gap in early-stage life sciences funding in Europe. Generalist venture funds often lack the specialized knowledge required to evaluate deep tech and regulatory-heavy ventures, leading to under-indexing in this crucial asset class.
That is why we launched Springboard Health. We believe this is the definitive moment for a specialized, expert-driven fund to back the next generation of category-defining founders.
Leadership
Dr. Yonathan Goldwasser
MD, Managing Director
Dr. Andreas Schmidt
MD, Managing Director
Investment Thesis
Smarter Healthcare Systems
AI-driven clinical workflows, diagnostics, administrative automation, value-based care infrastructure.
Biopharma
Value Chain
R&D acceleration, clinical trial optimization, manufacturing innovation, regulatory intelligence.
Frontier Tech
in Health
Robotics, computational biology, single-molecule diagnostics, novel modalities.
Bio-Resilience & Dual-Use Innovation
Pandemic preparedness, biosecurity, defense-adjacent life sciences.
The Edge
Expert network as infrastructure
Over 40+ active domain experts deeply integrated into our pipeline. By embedding scientific operators directly into the diligence and portfolio support processes, we make investment decisions backed by grounded operational reality.
Syndicate track record
A rapidly proven deal flow loop. Since 2022, the Syndicate has executed 30+ strategic investments alongside top-tier global lead investors, creating robust compounding network effects.
Europe-centric, globally connected
We have built a deep-rooted localized network in the DACH region, augmented by high-quality, cross-border deal access across North America and Israel.
Who we work with
Springboard Health partners with family offices, Mittelstand industrial companies, pharma corporates, and state-backed innovation investors seeking focused, specialist exposure to early-stage health tech and life sciences innovation.